Inovio developing foot & mouth disease vaccine under US R&D agreement
This article was originally published in Scrip
Inovio Pharmaceuticals entered into a cooperative research and development agreement (CRADA) with the US Department of Homeland Security (DHS) Science and Technology Directorate Plum Island Animal Disease Center to evaluate the efficacy of the company's SynCon vaccines in foot & mouth disease (FMD), one of the most infectious farm animal diseases, which is capable of rapidly infecting large numbers of animals, including cattle, swine, sheep and goats.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.